Ideaya Biosciences Inc (IDYA) — Cash Flow-to-Debt Ratio
Ideaya Biosciences Inc (IDYA) has a Cash Flow-to-Debt Ratio of -0.81x as of March 2026, meaning its operating cash flow of $-75.17 Million could theoretically repay -1% of its total liabilities ($93.08 Million) in one year. See Ideaya Biosciences Inc (IDYA) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Ideaya Biosciences Inc Cash Flow-to-Debt Ratio (2017–2025)
Historical debt coverage capacity for Ideaya Biosciences Inc across 9 annual periods. Also explore Ideaya Biosciences Inc net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Ideaya Biosciences Inc (2017–2025)
Year-by-year debt coverage analysis for Ideaya Biosciences Inc. For market capitalisation and broader financial context, see IDYA market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.82x | $-71.10 Million | $86.39 Million | ▲ +78.4% |
| 2024 | -3.81x | $-247.58 Million | $64.94 Million | ▲ +6.6% |
| 2023 | -4.08x | $-115.22 Million | $28.23 Million | ▼ -80.4% |
| 2022 | -2.26x | $-87.17 Million | $38.51 Million | ▼ -224.0% |
| 2021 | -0.70x | $-55.78 Million | $79.83 Million | ▼ -226.0% |
| 2020 | 0.55x | $55.46 Million | $100.00 Million | ▲ +117.8% |
| 2019 | -3.12x | $-39.31 Million | $12.60 Million | ▼ -1543.4% |
| 2018 | -0.19x | $-27.62 Million | $145.49 Million | ▲ +48.4% |
| 2017 | -0.37x | $-12.22 Million | $33.22 Million | — |